Abstract:Although Down syndrome (DS) can be diagnosed prenatally, currently there are no effective treatments to lessen the intellectual disability (ID) which is a hallmark of this disorder. Furthermore, starting as early as the third decade of life, DS individuals exhibit the neuropathological hallmarks of Alzheimer’s disease (AD) with subsequent dementia, adding substantial emotional and financial burden to their families and society at large. A potential therapeutic strategy emerging from the study of trisomic mouse… Show more
“…Since functional deficits associated with DS correspond with endpoints affected by MCS, we previously conducted a study to test the hypothesis that MCS would improve learning and attention in Ts65Dn offspring. This study yielded evidence for substantial cognitive benefits, as well as an improved regulation of negative affect in Ts65Dn mice (Moon et al, 2010; Strupp et al, 2016). …”
mentioning
confidence: 68%
“…Our group has demonstrated that supplementing the maternal diet with additional choline has numerous beneficial effects for Ts65Dn and 2N offspring, including improvements in attention, emotion regulation, spatial memory, hippocampal neurogenesis, and protection of cholinergic neurons in the MSN (Ash et al, 2014; Moon et al, 2010; Strupp et al, 2016; Velazquez et al, 2013). Choline supply is critical for the developing brain because it is a precursor of acetylcholine, a key neurotransmitter for regulating neuronal proliferation, differentiation, migration, maturation, plasticity, and survival, as well as synapse formation (Abreu-Villaca et al, 2011; Albright et al, 1999; Blusztajn, 1998; Cermak et al, 1999; Zeisel, 2011).…”
Section: Discussionmentioning
confidence: 99%
“…Our group has been investigating maternal choline supplementation (MCS) as a potential prenatal therapeutic strategy for DS (Strupp et al, 2016). Decades of research has revealed that in normal rodents supplementing the maternal diet with additional choline during gestation and/or lactation produces lifelong improvements in spatial cognition and attention of the offspring, as well as changes in MSN cholinergic neurons and electrophysiological indices of hippocampal function (Meck and Williams, 2003; Zeisel and Niculescu, 2006).…”
The Ts65Dn mouse model of Down syndrome (DS) and Alzheimer’s disease (AD) exhibits cognitive impairment and degeneration of basal forebrain cholinergic neurons (BFCNs). Our prior studies demonstrated that maternal choline supplementation (MCS) improves attention and spatial cognition in Ts65Dn offspring, normalizes hippocampal neurogenesis, and lessens BFCN degeneration in the medial septal nucleus (MSN). Here we determined whether (i) BFCN degeneration contributes to attentional dysfunction, and (ii) whether the attentional benefits of perinatal MCS are due to changes in BFCN morphology. Ts65Dn dams were fed either a choline-supplemented or standard diet during pregnancy and lactation. Ts65Dn and disomic (2N) control offspring were tested as adults (12–17 months of age) on a series of operant attention tasks, followed by morphometric assessment of BFCNs. Ts65Dn mice demonstrated impaired learning and attention relative to 2N mice, and MCS significantly improved these functions in both genotypes. We also found, for the first time, that the number of BFCNs in the nucleus basalis of Meynert/substantia innominata (NBM/SI) was significantly increased in Ts65Dn mice relative to controls. In contrast, the number of BFCNs in the MSN was significantly decreased. Another novel finding was that the volume of BFCNs in both basal forebrain regions was significantly larger in Ts65Dn mice. MCS did not normalize any of these morphological abnormalities in the NBM/SI or MSN. Finally, correlational analysis revealed that attentional performance was inversely associated with BFCN volume, and positively associated with BFCN density. These results support the lifelong attentional benefits of MCS for Ts65Dn and 2N offspring and have profound implications for translation to human DS and pathology attenuation in AD.
“…Since functional deficits associated with DS correspond with endpoints affected by MCS, we previously conducted a study to test the hypothesis that MCS would improve learning and attention in Ts65Dn offspring. This study yielded evidence for substantial cognitive benefits, as well as an improved regulation of negative affect in Ts65Dn mice (Moon et al, 2010; Strupp et al, 2016). …”
mentioning
confidence: 68%
“…Our group has demonstrated that supplementing the maternal diet with additional choline has numerous beneficial effects for Ts65Dn and 2N offspring, including improvements in attention, emotion regulation, spatial memory, hippocampal neurogenesis, and protection of cholinergic neurons in the MSN (Ash et al, 2014; Moon et al, 2010; Strupp et al, 2016; Velazquez et al, 2013). Choline supply is critical for the developing brain because it is a precursor of acetylcholine, a key neurotransmitter for regulating neuronal proliferation, differentiation, migration, maturation, plasticity, and survival, as well as synapse formation (Abreu-Villaca et al, 2011; Albright et al, 1999; Blusztajn, 1998; Cermak et al, 1999; Zeisel, 2011).…”
Section: Discussionmentioning
confidence: 99%
“…Our group has been investigating maternal choline supplementation (MCS) as a potential prenatal therapeutic strategy for DS (Strupp et al, 2016). Decades of research has revealed that in normal rodents supplementing the maternal diet with additional choline during gestation and/or lactation produces lifelong improvements in spatial cognition and attention of the offspring, as well as changes in MSN cholinergic neurons and electrophysiological indices of hippocampal function (Meck and Williams, 2003; Zeisel and Niculescu, 2006).…”
The Ts65Dn mouse model of Down syndrome (DS) and Alzheimer’s disease (AD) exhibits cognitive impairment and degeneration of basal forebrain cholinergic neurons (BFCNs). Our prior studies demonstrated that maternal choline supplementation (MCS) improves attention and spatial cognition in Ts65Dn offspring, normalizes hippocampal neurogenesis, and lessens BFCN degeneration in the medial septal nucleus (MSN). Here we determined whether (i) BFCN degeneration contributes to attentional dysfunction, and (ii) whether the attentional benefits of perinatal MCS are due to changes in BFCN morphology. Ts65Dn dams were fed either a choline-supplemented or standard diet during pregnancy and lactation. Ts65Dn and disomic (2N) control offspring were tested as adults (12–17 months of age) on a series of operant attention tasks, followed by morphometric assessment of BFCNs. Ts65Dn mice demonstrated impaired learning and attention relative to 2N mice, and MCS significantly improved these functions in both genotypes. We also found, for the first time, that the number of BFCNs in the nucleus basalis of Meynert/substantia innominata (NBM/SI) was significantly increased in Ts65Dn mice relative to controls. In contrast, the number of BFCNs in the MSN was significantly decreased. Another novel finding was that the volume of BFCNs in both basal forebrain regions was significantly larger in Ts65Dn mice. MCS did not normalize any of these morphological abnormalities in the NBM/SI or MSN. Finally, correlational analysis revealed that attentional performance was inversely associated with BFCN volume, and positively associated with BFCN density. These results support the lifelong attentional benefits of MCS for Ts65Dn and 2N offspring and have profound implications for translation to human DS and pathology attenuation in AD.
“…Organizational brain changes may result from choline’s role as the precursor to phosphatidylcholine, a major constituent of neuronal cellular membranes, and, to a lesser extent, as a precursor of ACh, which is a key ontogenetic signal during development [34,51,57,102]. Additionally, long-term effects of early choline supplementation may be related to epigenetic factors with lasting effects on gene expression, secondary to choline’s role as a methyl donor [39,103–105].…”
Section: Discussionmentioning
confidence: 99%
“…A potential treatment approach involves maternal dietary supplementation with choline, an essential nutrient involved in neural tube closure, organogenesis, central nervous system cell membrane synthesis, and methylation-dependent gene expression [36,38–44]. MCS has both immediate and long-term beneficial effects in healthy disomic rats and mice [44–57], and in rodent models of prenatal ethanol exposure, Rett syndrome, and status epilepticus [58–63]. To explore the effects of early choline supplementation on cholinergic innervation and activity in the hippocampus of the adult brain, we used a MCS paradigm and studied adult male Ts65Dn and 2N offspring.…”
Down syndrome (DS), caused by trisomy of chromosome 21, is marked by intellectual disability (ID) and early onset of Alzheimer’s disease (AD) neuropathology including hippocampal cholinergic projection system degeneration. Here we determined the effects of age and maternal choline supplementation (MCS) on hippocampal cholinergic deficits in Ts65Dn mice. Ts65Dn mice and disomic (2N) littermates sacrificed at ages 6–8 and 14–18 mos were used for an aging study, and Ts65Dn and 2N mice derived from Ts65Dn dams were maintained on either a choline-supplemented or a choline-controlled diet (conception to weaning) and examined at 14–18 mos for MCS studies. In the latter, mice were behaviorally tested on the radial arm Morris water maze (RAWM) and hippocampal tissue was examined for intensity of choline acetyltransferase (ChAT) immunoreactivity. Hippocampal ChAT activity was evaluated in a separate cohort. ChAT-positive fiber innervation was significantly higher in the hippocampus and dentate gyrus in Ts65Dn mice compared with 2N mice, independent of age or maternal diet. Similarly, hippocampal ChAT activity was significantly elevated in TS65Dn mice compared to 2N mice, independent of maternal diet. A significant increase with age was seen in hippocampal cholinergic innervation of 2N mice, but not Ts65Dn mice. Degree of ChAT intensity correlated negatively with spatial memory ability in unsupplemented 2N and Ts65Dn mice, but positively in MCS 2N mice. The increased innervation produced by MCS appears to improve hippocampal function, making this a therapy that may be exploited for future translational approaches in human DS.
Down syndrome (DS), trisomy 21, is marked by intellectual disability and a premature aging profile including degeneration of the basal forebrain cholinergic neuron (BFCN) projection system, similar to Alzheimer's disease (AD). Although data indicate that perinatal maternal choline supplementation (MCS) alters the structure and function of these neurons in the Ts65Dn mouse model of DS and AD (Ts), whether MCS affects the molecular profile of vulnerable BFCNs remains unknown. We investigated the genetic signature of BFCNs obtained from Ts and disomic (2N) offspring of Ts65Dn dams maintained on a MCS diet (Ts+, 2N+) or a choline normal diet (ND) from mating until weaning, then maintained on ND until 4.4–7.5 months of age. Brains were then collected and prepared for choline acetyltransferase (ChAT) immunohistochemistry and laser capture microdissection followed by RNA extraction and custom‐designed microarray analysis. Findings revealed upregulation of select transcripts in classes of genes related to the cytoskeleton (Tubb4b), AD (Cav1), cell death (Bcl2), presynaptic (Syngr1), immediate early (Fosb, Arc), G protein signaling (Gabarap, Rgs10), and cholinergic neurotransmission (Chrnb3) in Ts compared to 2N mice, which were normalized with MCS. Moreover, significant downregulation was seen in select transcripts associated with the cytoskeleton (Dync1h1), intracellular signaling (Itpka, Gng3, and Mlst8), and cell death (Ccng1) in Ts compared to 2N mice that was normalized with MCS. This study provides insight into genotype‐dependent differences and the effects of MCS at the molecular level within a key vulnerable cell type in DS and AD.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.